Star Health and Allied Insurance Company Limited will conduct an in-person meeting with analysts and institutional investors on Wednesday, August 05, 2026, in Hong Kong. The event aims to engage with key global investment firms, providing them an opportunity to discuss the insurer’s strategic outlook and performance directly with management. This engagement reflects the company’s continued focus on maintaining transparent communication with its international investor base.

The disclosure was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company notified both the Bombay Stock Exchange and the National Stock Exchange of India Limited regarding the schedule. Jayashree Sethuraman, Company Secretary & Compliance Officer, signed the intimation.

Meeting Schedule

The company has allocated specific one-hour slots for each participating firm. All timings are listed in Hong Kong time.

The company noted that the schedule is subject to change due to exigencies on the part of the analysts or investors. A presentation deck related to the meeting is available for download via the company’s official website.

Regulatory Compliance

The intimation was filed under reference number SHAI/B & S/SE/62/2026-27. The disclosure ensures adherence to SEBI’s listing obligations regarding timely communication of material events to stock exchanges. The details are also hosted on the company’s website at www.starhealth.in for public access.

Star Health and Allied Insurance Company Limited has released the audio recording of its first quarter fiscal year 2027 (Q1 FY2027) earnings call, allowing investors and analysts to review management's commentary on recent financial performance. The disclosure was made on July 30, 2026, following the earlier intimation of the call scheduled on July 16, 2026. This action ensures transparency and provides stakeholders with access to detailed discussions regarding the insurer's operational metrics and strategic outlook for the period.

Regulatory Disclosure Details

The company submitted the link to the audio recording to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE). The submission was categorized under reference number SHAI/B & S/SE/60/2026-27. Jayashree Sethuraman, Company Secretary & Compliance Officer, digitally signed and approved the document on July 30, 2026, at 11:38:05 IST. The filing serves as a compliance measure under listing regulations, ensuring that market participants have equitable access to material information discussed during the conference call.

Access Information

Investors can access the earnings call recording through the following web link provided in the exchange filing:

The recording covers the discussions held during the Q1 FY2027 earnings call, which was initially announced via letter SHAI/B & S/SE/52/2026-27 dated July 16, 2026. The company emphasized that this information is for the kind information and records of the listing departments.

What This Means for Investors

While the filing itself does not disclose specific financial figures such as net profit, revenue, or gross written premium (GWP), it confirms the availability of primary source data for due diligence. Investors are advised to listen to the recording to understand management's perspective on key performance indicators, including loss ratios, acquisition costs, and growth strategies for the health insurance segment. The release aligns with standard corporate governance practices, ensuring that all shareholders have equal opportunity to assess the company's performance beyond summarized press releases.

No other material announcements, such as dividend declarations or board meeting outcomes, were included in this specific communication. The focus remains solely on providing access to the earnings call transcript audio.